<DOC>
	<DOCNO>NCT00944632</DOCNO>
	<brief_summary>The purpose study determine safety efficacy three concentration ZK 245186 ointment vehicle increase body surface area treatment atopic dermatitis obtain dose-response information three concentration .</brief_summary>
	<brief_title>Dose Escalation Different Concentrations ZK 245186 Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>diagnosis atopic dermatitis ( Hanifin Rajka criterion ) mild moderate atopic dermatitis begin study washout period systemic topical treatment atopic dermatitis female must use effective contraception pregnant lactate woman condition opinion investigator may pose risk interfere evaluation study widespread atopic dermatitis require systemic treatment diagnose immunocompromised status skin diseases atopic dermatitis treatment area mental handicap legally incompetent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>